Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
World J Gastroenterol ; 29(15): 2222-2240, 2023 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-37124883

RESUMO

Worldwide, gastric cancer (GC) is the fifth most commonly diagnosed malignancy. It has a reduced prevalence but has maintained its poor prognosis being the fourth leading cause of deaths related to cancer. The highest mortality rates occur in Asian and Latin American countries, where cases are usually diagnosed at advanced stages. Overall, GC is viewed as the consequence of a multifactorial process, involving the virulence of the Helicobacter pylori (H. pylori) strains, as well as some environmental factors, dietary habits, and host intrinsic factors. The tumor microenvironment in GC appears to be chronically inflamed which promotes tumor progression and reduces the therapeutic opportunities. It has been suggested that inflammation assessment needs to be measured qualitatively and quantitatively, considering cell-infiltration types, availability of receptors to detect damage and pathogens, and presence or absence of aggressive H. pylori strains. Gastrointestinal epithelial cells express several Toll-like receptors and determine the first defensive line against pathogens, and have been also described as mediators of tumorigenesis. However, other molecules, such as cytokines related to inflammation and innate immunity, including immune checkpoint molecules, interferon-gamma pathway and NETosis have been associated with an increased risk of GC. Therefore, this review will explore innate immune activation in the context of premalignant lesions of the gastric epithelium and established gastric tumors.


Assuntos
Infecções por Helicobacter , Helicobacter pylori , Neoplasias Gástricas , Humanos , Neoplasias Gástricas/metabolismo , Imunidade Inata , Citocinas/metabolismo , Inflamação/metabolismo , Receptores Toll-Like/metabolismo , Mucosa Gástrica/metabolismo , Microambiente Tumoral
2.
J Air Waste Manag Assoc ; 55(9): 1289-97, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16259424

RESUMO

Environmental agencies are currently in the process of implementing a new air management program, which includes the improvement of fuel quality. In this work, exhaust emissions data and estimated relative risk for various fuels testing in-use vehicles, equipped with three different exhaust emission control technologies, are presented. Aromatics, sulfur, and olefins contents; type of oxygenated compound; and Reid vapor pressure were varied. The aim also includes calculating the ozone (O3) forming potential and a relative cancer risk of emissions from current and formulated gasoline blends in Mexico. The proposed gasoline decreases carbon monoxide, total hydrocarbons (THC), and nitrogen oxides emissions by 18 and 14%, respectively, when compared with gasoline sold in the rest of the country and within ozone nonattainment metropolitan areas in Mexico, respectively.


Assuntos
Poluentes Atmosféricos/análise , Gasolina/análise , Emissões de Veículos/análise , Poluentes Atmosféricos/efeitos adversos , Poluição do Ar/prevenção & controle , Alcenos/análise , Monóxido de Carbono/análise , Cidades , Etanol/análise , Humanos , Hidrocarbonetos Aromáticos/análise , Éteres Metílicos/análise , México , Veículos Automotores/classificação , Neoplasias/induzido quimicamente , Óxidos de Nitrogênio/análise , Ozônio/análise , Medição de Risco , Enxofre/análise , Emissões de Veículos/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA